Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025
|発行||Meticulous Market Research Pvt. Ltd.||商品コード||906596|
|出版日||ページ情報||英文 221 Pages
|免疫測定市場：製品、プラットフォーム、用途、エンドユーザー、地域別の世界市場予測 Immunoassay Market by Product (Kits & Reagents, Analyzers, Software), Platform (Chemiluminescence, Radioimmunoassays) Application (Infectious Diseases, Cardiology), End User (Hospitals, Academic Laboratories), and Geography - Global Forecast to 2025|
|出版日: 2019年08月13日||ページ情報: 英文 221 Pages||
The global immunoassay market is expected to grow at a CAGR of 5.9% from 2019 to reach $19.76 billion by 2025.
Succeeding an extensive secondary and primary researchand in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges. The high growth of immunoassays market is attributed to factors such as increasing incidences of chronic and infectious diseases, increasing use of immunoassay in oncology, rise in drug and alcohol testing, and technological advancements in immunoassay. On the other hand, limitations of immunoassay and development of alternative technologies are expected to hinder the adoption of immunoassay products. Emerging markets and increasing epidemic potentials offer significant growth opportunities for the players operating in this market.
The global immunoassay market study presents historical market data in terms of values (2017 and 2018), estimated current data (2019), and forecasts for 2025-by product (immunoassay kits & reagents, immunoassay analyzers, immunoassay software & services), platforms (chemiluminescence immunoassays, fluorescence immunoassays, colorimetric immunoassays, radioimmunoassays, other platforms), application (infectious diseases, cardiology, endocrinology, oncology, bone & mineral disorders, autoimmune disorders, allergy, other applications), end user (hospitals & clinics, clinical laboratories/reference labs, blood banks, pharmaceutical and biotechnology companies, research & academic laboratories, other end users). The study also evaluates industry competitors and analyzes the market at regional and country level.
On the basis of product, immunoassay kits and reagents segment is estimated to account for the largest share of this market in 2019. The large share of this segment is mainly attributed to increasing number of immunoassay tests being performed across the globe leading to recurrent purchase of kits and reagents. Among kits and reagents segment, ELISpot kits and reagents segment is projected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to rising global incidence of chronic diseases, increasing vaccine development to address the challenge of antimicrobial resistance, and technological advancements in ELISpot assay kits and analyzers.
On the basis of application, infectious diseases segment is estimated to account for the largest share of the immunoassay market in 2019, mainly due to rising incidence of infectious diseases and growing adoption of immunoassay diagnostics in infectious diseases. However, oncology segment is expected to grow at the highest CAGR in the forecast period. Rising prevalence of cancer, increasing focus towards tumor market development, technological advancements, and growing awareness about cancer are expected to drive the growth of this market.
An in-depth analysis of the geographical scenario of the industry provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. North America accounted for the largest share of immunoassays market, mainly due to rising incidence of infectious diseases, growing prevalence of cancer, rising healthcare expenditure, presence of major players for immunoassay in the region, and highly developed healthcare infrastructure.
The key players operating in the global immunoassays market are: F. Hoffman La Roche AG (Switzerland), Abbott Laboratories (U.S.), Siemens AG (Germany), Danaher Corporation (U.S.), Sysmex Corporation (Japan), bioMerieux (France), Ortho Clinical Diagnostics (U.S.), DiaSorin SPA (Italy), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (U.S.), Becton, Dickinson and Company (U.S.), Merck (Germany), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), PerkinElmer (U.S.), Quidel Corporation (U.S.), Bio-Techne Corporation (U.S.), and Mindray (China) among others.